China Resources Pharmaceutical Unit Secures Approval for RMB 10 Billion Corporate Bond IssuancePUBT·Nov 16, 2026 at 11:25 AM03320+0.56%
Weekly Recap | CHINARES PHARMA -5.79%, consensus target above spotWeekly Review·Nov 14, 2026 at 05:30 AM03320+0.56%
China Resources Pharmaceutical Group Subsidiary CR Pharmaceutical Commercial’s Nine-Month Net Profit Rises to RMB 1.75 BillionPUBT·Oct 30, 2026 at 09:18 AM03320+0.56%
China Resources Pharmaceutical Group Subsidiary CR Pharmaceutical Holdings’ Nine-Month Net Profit Falls to RMB 6.97 BillionPUBT·Oct 28, 2026 at 09:53 AM03320+0.56%
China Resources Pharma Discloses Nine-Month Unaudited Results of Dong-E-E-JiaoTip Ranks·Oct 23, 2026 at 10:40 AM03320+0.56%000423-0.09%
China Resources Pharmaceutical Subsidiary Tasly Posts Higher Profit on Lower RevenueTip Ranks·Oct 23, 2026 at 10:40 AM03320+0.56%600535+0.21%
China Resources Pharmaceutical Completes RMB 800 Million Medium-Term Note IssuancePUBT·Oct 23, 2026 at 09:46 AM03320+0.56%
China Resources Pharmaceutical Raises RMB900 Million in Second Tranche of 2026 PRC BondsTip Ranks·Oct 16, 2026 at 04:37 PM03320+0.56%
China Resources Pharma Subsidiary Starts Pre-Bidding for Potential Share IssuanceTip Ranks·Oct 16, 2026 at 01:11 PM03320+0.56%
AI Infrastructure Deals Fuel Hong Kong Mid-Caps' Strategic ShiftsGlobal Report·Oct 16, 2026 at 09:16 AM03320+0.56%020030.00%
CHINARES PHARMA 's DC7001A Capsules Approved by US FDA for Clinical TrialsAASTOCKS News·Oct 12, 2026 at 04:55 AM03320+0.56%
One Hong Kong IPO, Bid 1,235 Times Over — and the Market Beyond ItGlobal Report·Oct 6, 2026 at 10:49 AM01473-0.93%03320+0.56%
Three Pillars of Hong Kong's Consumer Sector Transformation: Pharma, Gaming and Auto FinanceGlobal Report·Oct 6, 2026 at 10:14 AM03320+0.56%01119+1.67%
Surgical Robotics Breaks Into Singapore as Medical AI Firms Cut CostsGlobal Report·Oct 6, 2026 at 09:17 AM01499-2.80%02675-3.15%
Dual 10-Billion Deals Reshape Hong Kong Small-CapsGlobal Report·Sep 29, 2026 at 09:15 AM01341-2.78%03320+0.56%